MYCN and astrocytoma (excluding glioblastoma): For instance, N-Myc amplification changes the classification and worsens the prognosis of spinal cord ependymoma, as do H3 K27M, TP53, and TERT promoter mutations, among many, worsen the prognosis of astrocytomas.